Replimune Group Earnings Estimates, EPS & Revenue | NASDAQ:REPL

Comments

Replimune Group Inc Earnings Estimates

REPLNASDAQ

Trade with Public

$7.22

-0.32-4.24%

At close: Mar 27, 5:00 PM EST

$7.23

0.010.14%

After Hours: 6:58 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Replimune Group Earnings Estimates, EPS & Revenue | NASDAQ:REPL

Replimune Group (REPL) is scheduled to report Q4 earnings on May 21, 2026. Analysts estimate EPS of $-0.75 and quarterly revenue of $12.58M.

In the most recent quarter (Q3), Replimune Group reported EPS of $-0.77, beating estimates of $-0.83 by 0.07%. Revenue came in at $0.00, missing the estimate of $3.20M by 1.00%.

Over the last 4 quarters, Replimune Group has averaged an EPS surprise of 0.13% and a revenue surprise of 1.00%.

Earnings Date

May 21

EPS Estimate

$-0.750

Quarterly Revenue Estimate

$12.58M

Annual Revenue
(as of Dec 31)

–

Replimune Group Earnings History

Analyze the earnings history of Replimune Group using advanced sorting and filters.

Loading calendar...

Replimune Group (REPL) Earnings Per Share

The chart below shows Replimune Group's reported EPS compared to analyst estimates over recent quarters.

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	2026-02-03	$-0.77	$-0.83	7.23 %
Q2	2025-11-06	$-0.90	$-0.82	-9.76 %
Q1	2025-08-07	$-0.95	$-0.82	-15.8 %
Q4	2025-05-22	$-0.82	$-0.69	-18.8 %

Replimune Group (REPL) Revenue

The chart below shows Replimune Group's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Replimune Group (NASDAQ:REPL) reporting earnings?

Replimune Group (REPL) is scheduled to report earnings on May 21, 2026. The last reported earnings were for reported on February 3, 2026 for Q3.

What were the latest earnings per share (EPS) for Replimune Group (NASDAQ:REPL)?

The Actual EPS was $-0.77, which beat the estimate of $-0.83.

What were Replimune Group’s (NASDAQ:REPL) revenues?

The Actual Revenue was $0.00, which missed the estimate of $3.20M.

People Also Watch

Bright Minds Biosciences Inc

Tectonic Therapeutic Inc

NASDAQ:TECX

$28.80

-1.87%

Gyre Therapeutics Inc

4D Molecular Therapeutics Inc

Replimune Group Earnings Estimates, EPS & Revenue | NASDAQ:REPL

Replimune Group (REPL) is scheduled to report Q4 earnings on May 21, 2026. Analysts estimate EPS of $-0.75 and quarterly revenue of $12.58M.

In the most recent quarter (Q3), Replimune Group reported EPS of $-0.77, beating estimates of $-0.83 by 0.07%. Revenue came in at $0.00, missing the estimate of $3.20M by 1.00%.

Over the last 4 quarters, Replimune Group has averaged an EPS surprise of 0.13% and a revenue surprise of 1.00%.

Earnings Date

May 21

EPS Estimate

$-0.750

Quarterly Revenue Estimate

$12.58M

Annual Revenue
(as of Dec 31)

–